Wall Street Experts
ver. ZuMIgo(08/25)
IOL Chemicals and Pharmaceuticals Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 20 524
EBIT TTM (mln): 1 487
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
Rok finansowy |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
2,026 |
3,179 |
3,019 |
3,494 |
3,894 |
4,707 |
4,815 |
5,635 |
3,847 |
5,804 |
7,018 |
9,621 |
16,550 |
18,635 |
19,461 |
21,684 |
22,017 |
21,328 |
Przychód Δ r/r |
0.0% |
56.9% |
-5.1% |
15.8% |
11.4% |
20.9% |
2.3% |
17.0% |
-31.7% |
50.9% |
20.9% |
37.1% |
72.0% |
12.6% |
4.4% |
11.4% |
1.5% |
-3.1% |
Marża brutto |
15.3% |
19.0% |
17.9% |
19.4% |
38.0% |
36.3% |
37.7% |
34.4% |
27.4% |
27.5% |
30.3% |
26.0% |
35.5% |
41.8% |
42.2% |
26.4% |
28.4% |
22.1% |
EBIT (mln) |
153 |
293 |
260 |
295 |
-4,041 |
38 |
30 |
51 |
-754 |
-386 |
55 |
779 |
3,536 |
5,168 |
5,441 |
2,123 |
1,736 |
1,677 |
EBIT Δ r/r |
0.0% |
91.1% |
-11.3% |
13.5% |
-1468.9% |
-100.9% |
-22.1% |
71.8% |
-1584.3% |
-48.9% |
-114.2% |
1322.0% |
354.0% |
46.1% |
5.3% |
-61.0% |
-18.2% |
-3.4% |
EBIT (%) |
7.6% |
9.2% |
8.6% |
8.4% |
-103.8% |
0.8% |
0.6% |
0.9% |
-19.6% |
-6.6% |
0.8% |
8.1% |
21.4% |
27.7% |
28.0% |
9.8% |
7.9% |
7.9% |
Koszty finansowe (mln) |
66 |
130 |
149 |
149 |
368 |
432 |
0 |
560 |
410 |
454 |
621 |
590 |
466 |
160 |
9 |
24 |
107 |
161 |
EBITDA (mln) |
188 |
368 |
360 |
395 |
-3,804 |
687 |
891 |
927 |
-55 |
367 |
982 |
1,211 |
4,153 |
5,850 |
6,113 |
2,854 |
2,459 |
2,306 |
EBITDA(%) |
9.3% |
11.6% |
11.9% |
11.3% |
-97.7% |
14.6% |
18.5% |
16.5% |
-1.4% |
6.3% |
14.0% |
12.6% |
25.1% |
31.4% |
31.4% |
13.2% |
11.2% |
10.8% |
Podatek (mln) |
11 |
40 |
-16 |
46 |
29 |
-10 |
14 |
18 |
-88 |
15 |
13 |
36 |
994 |
1,720 |
1,268 |
572 |
495 |
472 |
Zysk Netto (mln) |
76 |
124 |
127 |
100 |
62 |
48 |
16 |
33 |
-667 |
-400 |
47 |
277 |
2,367 |
3,613 |
4,446 |
1,677 |
1,391 |
1,344 |
Zysk netto Δ r/r |
0.0% |
63.7% |
2.7% |
-21.1% |
-38.3% |
-23.1% |
-66.6% |
107.7% |
-2120.1% |
-39.9% |
-111.7% |
493.1% |
754.5% |
52.6% |
23.0% |
-62.3% |
-17.0% |
-3.4% |
Zysk netto (%) |
3.7% |
3.9% |
4.2% |
2.9% |
1.6% |
1.0% |
0.3% |
0.6% |
-17.3% |
-6.9% |
0.7% |
2.9% |
14.3% |
19.4% |
22.8% |
7.7% |
6.3% |
6.3% |
EPS |
9.18 |
10.26 |
8.18 |
4.69 |
2.52 |
1.85 |
0.61 |
1.21 |
-16.72 |
-7.6 |
0.83 |
4.93 |
42.11 |
63.51 |
76.21 |
28.56 |
23.7 |
22.9 |
EPS (rozwodnione) |
9.18 |
7.6 |
7.87 |
4.68 |
2.52 |
1.83 |
0.61 |
1.21 |
-16.63 |
-7.6 |
0.83 |
4.93 |
42.11 |
63.38 |
76.21 |
28.56 |
23.7 |
22.9 |
Ilośc akcji (mln) |
8 |
12 |
16 |
21 |
26 |
26 |
26 |
27 |
40 |
53 |
56 |
56 |
56 |
57 |
58 |
59 |
59 |
59 |
Ważona ilośc akcji (mln) |
8 |
16 |
16 |
21 |
26 |
26 |
26 |
27 |
40 |
53 |
56 |
56 |
56 |
57 |
58 |
59 |
59 |
59 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |